Fundraising Fox

Bellicum Pharmaceuticals

Houston, US · 3 known investors

Clinical-stage biopharmaceutical company developing controllable cell therapies, including next-generation CAR-T, TCR and allogeneic T cell products such as rivo-cel and the GoCAR-T candidate BPX-601.

Biotech

Founders & leadership

KM
Ken MoseleyNamed on SEC filing
TJ
Thomas J. FarrellNamed on SEC filing
JF
James F. BrownNamed on SEC filing
AM
Annemarie MoseleyNamed on SEC filing
JS
Joseph SenesacNamed on SEC filing
FM
Frank McGuyerNamed on SEC filing
DM
David M. SpencerNamed on SEC filing
DK
Dennis K. StoneNamed on SEC filing
KM
Kevin M. SlawinNamed on SEC filing

Investors · 3

Foresite CapitalLarkspur
RA CapitalBoston
Rapha Capital Management, LLCSurfsidevia Kevin M. Slawin · inferred

Reported raises · per SEC filings

Form D private placements

$114.2M disclosed across 2 rounds · 2011–2014

▶$94.4MraisedSep 2014 · 76 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • David M. SpencerExecutive Officer
  • Annemarie MoseleyExecutive Officer
  • Kevin M. SlawinDirector
  • Dennis K. StoneDirector
  • James F. BrownDirector
  • Frank McGuyerDirector
  • Ken MoseleyExecutive Officer
  • Thomas J. FarrellExecutive Officer, Director
Offering amount
$94.4M
Amount sold
$94.4M
Sales commissions
$3.1M
Placement agents
Jefferies LLC
First sale
Aug 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$19.9MraisedMar 2012 · 21 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Ken MoseleyExecutive Officer
  • Thomas J. FarrellExecutive Officer, Director
  • James F. BrownDirector
  • Annemarie MoseleyExecutive Officer
  • Joseph SenesacExecutive Officer
  • Frank McGuyerDirector
  • David M. SpencerExecutive Officer
  • Dennis K. StoneDirector
  • Kevin M. SlawinExecutive Officer, Director
Offering amount
$25M
Amount sold
$19.9M
Minimum investment
$1M
First sale
Nov 2011
Incorporated
Corporation, Delaware
Federal exemptions
06
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.